Paxman AB

32
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009806284
SEK
56.00
3.2 (6.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Paxman AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
41.00
7.00
-8.00
-12.00
-20.00
-2.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-18.00
-11.00
-3.00
-4.00
-1.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
32.00
15.00
2.00
-4.00
-8.00
3.00
Cash Flow from Investing Activities
-18.00
-25.00
-36.00
-24.00
-6.00
-20.00
Cash Flow from Financing Activities
0.00
-3.00
0.00
97.00
16.00
18.00
Net Cash Inflow / Outflow
15.00
-13.00
-34.00
68.00
1.00
1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Paxman AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
41.5
-43.813501
84.00
194.72%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-18.723
-19.211291
1.00
2.54%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
32.625
-62.636476
94.00
152.09%
Cash Flow from Investing Activities
-18.606
-7.567937
-11.00
-145.85%
Cash Flow from Financing Activities
0.721
76.799331
-76.00
-99.06%
Net Cash Inflow / Outflow
15.329
6.338971
9.00
141.82%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.589
-0.255947
0.00
330.13%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 108.71% vs 481.98% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
32.62
15.63
108.71%